Drug details

Vyvgart (efgartigimod alfa-fcab injection)

type of

Vyvgart (efgartigimod alfa-fcab) is a neonatal Fc receptor blocker indicated for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) antibody positive.

The drug is often used to treat Myasthenia gravis .

This drug may have the following side effects:

• sore throat
• fever, and
• hives, 
• difficulty breathing, 
• swelling of your face, lips, tongue, or throat, 
• severe dizziness, 

The following drugs are related to Vyvgart, either as a replacement or used together:

• Imuran (azathioprine)
• Sandimmune (cyclosporine)
• Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc injection)
• Mestinon (pyridostigmine)
• Rayos (prednisone delayed-release tablets)
• Prograf (tacrolimus)
• Protopic (tacrolimus)
• Rystiggo (rozanolixizumab-noli injection)